Progranulin Regulates Inflammation and Tumor.

Antiinflamm Antiallergy Agents Med Chem

Pathogenic Microbiology, Clinical Medical College, Weifang Medical University, Shandong 261053, China.

Published: January 2021

Progranulin (PGRN) mediates cell cycle progression and cell motility as a pleiotropic growth factor and acts as a universal regulator of cell growth, migration and transformation, cell cycle, wound healing, tumorigenesis, and cytotoxic drug resistance as a secreted glycoprotein. PGRN overexpression can induce the secretion of many inflammatory cytokines, such as IL-8, -6,-10, TNF-α. At the same time, this protein can promote tumor proliferation and the occurrence and development of many related diseases such as gastric cancer, breast cancer, cervical cancer, colorectal cancer, renal injury, neurodegeneration, neuroinflammatory, human atherosclerotic plaque, hepatocarcinoma, acute kidney injury, amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson's disease. In short, PGRN plays a very critical role in injury repair and tumorigenesis, it provides a new direction for succeeding research and serves as a target for clinical diagnosis and treatment, thus warranting further investigation. Here, we discuss the potential therapeutic utility and the effect of PGRN on the relationship between inflammation and cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475802PMC
http://dx.doi.org/10.2174/1871523018666190724124214DOI Listing

Publication Analysis

Top Keywords

cell cycle
8
cancer
5
progranulin regulates
4
regulates inflammation
4
inflammation tumor
4
tumor progranulin
4
pgrn
4
progranulin pgrn
4
pgrn mediates
4
cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!